PB2011: CHIDAMIDE COMBINED WITH THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (TC2D) AS AN ORAL QUADRUPLET REGIMEN FOR RELAPSED/REFRACTORY MYELOMA PATIENTS: INITIAL RESULTS OF A PHASE IIA, MULTICENTER TRIAL

Detalles Bibliográficos
Autores principales: Li, Y., He, J., Han, X., Zheng, G., Zhang, E., Chen, Q., Yang, Y., He, D., Zhao, Y., Fu, J., Shou, L., Jiang, W., Qian, S., Hu, H., He, H., Cai, Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429125/
http://dx.doi.org/10.1097/01.HS9.0000850876.64075.46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429125/
http://dx.doi.org/10.1097/01.HS9.0000850876.64075.46

Ejemplares similares